- Belgian trial of Paris attack suspect postponed to February 5
- India's muted response to Trump's Jerusalem move stokes Arab unease
- Gunmen seize building in Afghan capital, firing on security forces
- How to buy and sell bitcoin - CNN Video
- Peru VP says committed to governing if president ousted
- Myanmar government says case against Reuters journalists can proceed
- Thomas Fire on course to become California's largest-ever wildfire
- Erdogan defies Trump, says Turkey has own embassy plans for Jerusalem
- Bitcoin futures trading just got a lot bigger
- Moscow says U.S. and North Korea should start a dialogue: RIA
- Australia's embattled Turnbull seen weighing cabinet reshuffle to expl
- At least 61 dead after days of violence in Ethiopia's Oromiya region
- Philippines says Maoist rebels attacked soldiers on typhoon relief dut
- U.S. taxpayers rush to claim deductions under threat from tax bill
- Tiny stem cell companies close in on major heart disease goals
- OAS says Honduran presidential election should be redone
- India ruling party pulls ahead in election in Modi state after tight r
- Atlanta's Hartsfield-Jackson airport restores power after crippling outage
- Mayor: Fire behind power outage; cause unknown - CNN Video
- Three Indian TV channels call Gujarat state polls in favor of PM Modi'
Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit
(Reuters) - A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers’ failure to warn of internal bleeding risks by its blockbuster drug Xarelto.
The jury slapped the companies, which jointly developed the blood thinner, with $1.8 million in compensatory and $26 million in punitive damages, according to the couple’s lawyer.
The verdict marks the first trial loss in litigation over Xarelto. Bayer and J&J have won three previous cases in federal court.
(This version of the story corrects headline to $28 million instead of $29 million, corrects paragraph 2 to $1.8 million compensatory and $26 million punitive instead of $26 million compensatory and $1.8 million punitive)
Reporting by Anthony Lin; Editing by Chizu Nomiyama
Our Standards:The Thomson Reuters Trust Principles.